Mary Vansuch
Physician Assistant · Dublin, OHNPI 1639817679
Payments from drug & device makers
Across 235 payments — averaging $20.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$574
- Xeris Pharmaceuticals, Inc.$497
- Lilly USA, LLC$489
- Novo Nordisk$487
- Bayer$436
- Mannkind Corporation$385
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,860100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 13 | $574 |
| Xeris Pharmaceuticals, Inc. | 16 | $497 |
| Lilly USA, LLC | 42 | $489 |
| Novo Nordisk | 42 | $487 |
| Bayer | 17 | $436 |
| Mannkind Corporation | 9 | $385 |
| Corcept Therapeutics | 17 | $270 |
| BETA Bionics, Inc. | 10 | $257 |
| Cequr Corporation | 2 | $139 |
| Boehringer Ingelheim | 6 | $123 |
| Amgen | 6 | $121 |
| Medtronic | 4 | $105 |
| IBSA Pharma Inc. | 5 | $91 |
| Sanofi-aventis U.S. LLC | 4 | $91 |
| Novartis | 4 | $88 |
| Amneal Pharmaceuticals LLC | 4 | $85 |
| Radius Health, Inc. | 3 | $71 |
| Tandem Diabetes Care, Inc. | 6 | $69 |
| Antares Pharma, Inc. | 3 | $61 |
| Insulet Corporation | 3 | $59 |
| Pfizer | 2 | $53 |
| AbbVie | 3 | $51 |
| AstraZeneca(2 entities) | 2 | $37 |
| Sequel Med Tech, LLC | 1 | $27 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| Tolmar, Inc. | 1 | $20 |
| Ascensia Diabetes Care US Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Halozyme Inc | 1 | $17 |
| Abbott | 1 | $17 |
| RGH Enterprises LLC | 1 | $16 |
| Chiesi USA, Inc. | 1 | $15 |
| Lifescan, Inc. | 1 | $15 |
| Averitas Pharma Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,860 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 133 | $188,748 |
| MounjaroTirzepatide | 130 | $173,201 |
| TrulicityDulaglutide | 56 | $76,745 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 28 | $47,228 |
| JardianceEmpagliflozin | 39 | $46,248 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $32,032 |
| FarxigaDapagliflozin Propanediol | 23 | $21,647 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $17,633 |
| VascepaIcosapent Ethyl | 19 | $16,970 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $15,361 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $13,069 |
| KerendiaFinerenone | 13 | $9,318 |
| NovologInsulin Aspart | 19 | $7,781 |
| Novolog FlexpenInsulin Aspart | 27 | $7,670 |
| Xigduo XrDapaglifloz Propaned/Metformin | 11 | $6,906 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $489 | $249,946186 claims |
| Novo NordiskOzempic, Novolog | $487 | $196,529152 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $123 | $59,31751 claims |
| AstraZenecaFarxiga | $37 | $21,64723 claims |
| BayerKerendia | $436 | $9,31813 claims |
| IBSA Pharma Inc.Tirosint | $91 | $4,99016 claims |
| AbbVieSynthroid | $51 | $4,22537 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $85 | $2,953161 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Dublin
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
- Brook GramBeloit$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.